Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews · Epilepsy

No studies found 0 · 0%GRADE not reported 1 · 50%Very low 0 · 0%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Gastrointestinal adverse events · people with drug‐resistant focal epilepsy

1 finding from 1 review

Stiripentol add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
GRADE not reported

Gastrointestinal adverse events · participants with epilepsy (BECTS)

Sulthiame showed no clear difference in adverse effects (gastrointestinal) compared with levetiracetam (low certainty).

1 finding from 1 review

Sulthiame monotherapy for epilepsy 2021 · Cochrane Headline outcomes only
RR 0.76 [0.37, 1.56]
1 study · 43 participants
Low